Skip to content

Study of the Effect of Crocin-containing Drugs in Male Sexual Dysfunction

The Effect of Enhancement of Drug-containing Crocin-containing Drugs in Male Sexual Dysfunction Due to Antidepressant Drugs (SSRIs) in A Randomized Placebo Controlled Clinical Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130418013058N9
Enrollment
75
Registered
2018-07-18
Start date
2018-07-23
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Men Sexual Dysfunction. Unspecified sexual dysfunction not due to a substance or known physiological condition

Interventions

Intervention 1: Intervention group: Receiving One Capsule of Crocin (7.5 mg) for eight weeks. Intervention 2: Intervention group: Receiving one Capsule of Crocin (7.5 mg)+Ginseng (350 mg) for eight w

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Male married patients (between 18 and 45 years old) Patients with Major Sexual Dysfunction are Diagnosed with Impotence According to the Diagnostic and Statistical Manual of Mental Disorders, which are treated with Fluoxetine SSRI Antidepressants. IIEF less than 25 Fluoxetine Consumption at least 6 Weeks Before the Start of the Project The Ability to Understand the Generalities of the Study, Interventions and Possible Complications The same Level and Severity of Depression in the Studied Patients

Exclusion criteria

Exclusion criteria: Other Psychiatric Disorders The need to Use other Antidepressants During the 4 weeks of Treatment Substance Abuse During Sample Collection The Limiting Conditions of Life that Cause the Patient to not Complete the Course of Treatment Taking other Drugs Like Sildenafil or Cyproheptadine Sensitivity to Saffron The Diagnosis of Other Causes of Sexual Dysfunction, such as Vascular Problems, Diabetes, etc. in the patient

Design outcomes

Primary

MeasureTime frame
Depression and Anxiety Disorder. Timepoint: Before intervention, One and Two months later. Method of measurement: Beck Depression and Anxiety Questionnaire.

Secondary

MeasureTime frame
Side Effects of Crocin. Timepoint: Before intervention, one and two months later. Method of measurement: Questionnaire for Side Effect of Crocin.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Seyed Ahmad Mohajeri

Mashhad University of Medical Sciences

mohajeria@mums.ac.ir+98 51 3882 3251

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026